West Pharmaceutical Services, Inc. (NYSE:WST) announced a quarterly dividend on Thursday, July 20th, Zacks reports. Stockholders of record on Wednesday, October 18th will be given a dividend of 0.14 per share by the medical instruments supplier on Wednesday, November 1st. This represents a $0.56 annualized dividend and a dividend yield of 0.60%. The ex-dividend date of this dividend is Tuesday, October 17th. This is a boost from West Pharmaceutical Services’s previous quarterly dividend of $0.13.

West Pharmaceutical Services has increased its dividend payment by an average of 8.4% annually over the last three years and has raised its dividend every year for the last 24 years. West Pharmaceutical Services has a dividend payout ratio of 20.6% meaning its dividend is sufficiently covered by earnings. Equities analysts expect West Pharmaceutical Services to earn $3.00 per share next year, which means the company should continue to be able to cover its $0.56 annual dividend with an expected future payout ratio of 18.7%.

West Pharmaceutical Services (NYSE WST) traded down 0.59% during mid-day trading on Friday, hitting $92.93. 70,995 shares of the stock traded hands. The firm has a market cap of $6.84 billion, a P/E ratio of 38.46 and a beta of 1.12. West Pharmaceutical Services has a 52-week low of $70.17 and a 52-week high of $99.91. The firm’s 50-day moving average is $95.89 and its 200 day moving average is $88.40.

West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings data on Thursday, April 27th. The medical instruments supplier reported $0.81 EPS for the quarter, beating the consensus estimate of $0.55 by $0.26. The business had revenue of $387.70 million during the quarter, compared to analyst estimates of $380.42 million. West Pharmaceutical Services had a return on equity of 14.89% and a net margin of 11.88%. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.53 earnings per share. Equities analysts predict that West Pharmaceutical Services will post $2.73 EPS for the current fiscal year.

Several brokerages have recently weighed in on WST. Zacks Investment Research upgraded West Pharmaceutical Services from a “hold” rating to a “buy” rating and set a $108.00 price target for the company in a report on Friday, June 23rd. BidaskClub downgraded West Pharmaceutical Services from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 13th. Finally, Jefferies Group LLC restated a “hold” rating and set a $90.00 price target on shares of West Pharmaceutical Services in a report on Thursday, June 8th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $90.18.

In other news, CFO William J. Federici sold 54,996 shares of the firm’s stock in a transaction on Thursday, May 18th. The stock was sold at an average price of $95.45, for a total transaction of $5,249,368.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Daniel Malone sold 4,124 shares of the firm’s stock in a transaction on Tuesday, May 2nd. The shares were sold at an average price of $93.31, for a total value of $384,810.44. The disclosure for this sale can be found here. 1.90% of the stock is owned by company insiders.

WARNING: “West Pharmaceutical Services, Inc. (WST) Announces Dividend Increase – $0.14 Per Share” was originally published by American Banking News and is the property of of American Banking News. If you are reading this story on another domain, it was copied illegally and republished in violation of US & international trademark & copyright laws. The legal version of this story can be read at https://www.americanbankingnews.com/2017/07/21/west-pharmaceutical-services-inc-wst-announces-dividend-increase-0-14-per-share.html.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Dividend History for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.